Magnesium sulphate in preterm labour: what to know

The medicine is usually administered in hospital by a maternity team. It may be considered when birth is expected soon, based on your pregnancy, gestational stage, contractions, cervical changes, or another medical reason for early delivery. It is not a way to stop every episode of preterm labour. The team will explain the intended benefit for the baby and whether other treatments are also needed.

You may feel warm, flushed, thirsty, nauseated, or light-headed while it is being given. Staff may check your blood pressure, breathing, reflexes, urine output, and how you are feeling. These checks help the team adjust or stop treatment if needed.

Tell the team about kidney problems, breathing conditions, allergies, medicines, and any previous reaction to magnesium sulphate. During the infusion, report worsening nausea, marked weakness, blurred vision, increasing sleepiness, difficulty breathing, chest discomfort, or a change in your movements or awareness. Do not change or stop the infusion yourself.

Keep your questions focused on timing, monitoring, possible alternatives, and how the plan fits with neonatal care. If labour settles or the delivery plan changes, ask whether the medicine should continue.

If you are at home and have regular contractions, leaking fluid, vaginal bleeding, pelvic pressure, or reduced fetal movement, contact your maternity unit urgently rather than waiting for an appointment. During treatment, alert staff immediately about breathing difficulty, severe drowsiness, faintness, or new confusion.

Ask why magnesium sulphate is being recommended now, how it will be given, how long monitoring will last, what sensations are expected, and which symptoms should be reported straight away. You can also ask how the plan relates to the timing of birth and your baby's care after delivery.